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Tissue-resident memory CD8+ T (Trm) cells define a distinct non-recirculating subset. 
Trm cells constitute a first line of defense against local infections in barrier tissues, but 
they are also found in non-barrier tissues and play a role in antitumor immunity. Their 
differentiation in tissues and their phenotypical, transcriptional, and functional charac-
teristics are the object of active research. Herein, we will discuss the potential existence 
of committed CD8+ Trm precursors and the genealogy of memory CD8+ T cell subsets. 
In addition to the priming of naive T cells, there is some plasticity of antigen-experienced 
effector and memory T  cell subsets to generate Trm precursors. Local inflammation, 
antigen presentation, and cytokines drive Trm differentiation. It is of prime interest how 
specific dendritic cell subsets modulate priming and differentiation of Trm cells, as well 
as their reactivation within tissues. Research on how we can manipulate generation of 
memory T cells subsets is key for improved vaccination strategies.
Keywords: memory CD8+ T  cell, circulating memory, tissue-resident memory, infection, plasticity, priming, 
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ARe THeRe COMMiTTeD Trm PReCURSORS?
Dendritic cells (DCs) prime naive T cells in secondary lymphoid organs generating both a short-
term effector response and a memory response. Memory T cells are further subdivided based on 
their distribution and trafficking properties. Circulating memory T cells can be further subdivided 
as central memory T (Tcm) cells that re-circulate between secondary lymphoid organs, blood and 
lymph, and effector memory T (Tem) cells that can also access the tissues (1, 2). Conversely, a distinct 
subset of sessile tissue-resident memory T (Trm) cells has been defined in the last years. Trm cells 
are long-lived and confined in a wide variety of tissues, including barrier tissues, such as the skin and 
lung, where they comprise the first line of defense against local re-infections and provide superior 
protective immunity compared with circulating memory cells (3–7). However, Trm cells are also 
found in non-barrier tissues like brain (8), heart (9), and play a role in tumor immunity (Box 1) 
(10–12). Trm cells are phenotypically, transcriptionally, and functionally distinct from their circulat-
ing counterparts. Trm cells do not express the lymph node homing receptors CCR7 or CD62L, and 
expression of CD69 and the integrin CD103 is often used to define T cells as tissue resident (7, 13). 
However, CD103− CD69+ cells make up almost half of the dermal Trm population (3, 14), while the 
intestine and the lung contain subsets of T cells that lack CD103 and/or CD69 expression but are 
nonetheless capable of maintaining tissue residence (15–17). This phenotypic heterogeneity among 
Trm populations is dependent not only on the tissue of residence but also on how Trm cells are 
BOx 1 | Trm in immunity against tumors.
The relative contribution of different memory CD8+ T cell subsets to antitu-
mor immunity is starting to be explored. Data in human tumors show that 
the number of cells with a Trm phenotype infiltrating tumors correlates with 
a better overall survival in different cancers, including early stage non-small-
cell lung carcinoma, pulmonary squamous cell carcinoma, and high-grade 
serous epithelial ovarian cancer (11, 28–31). Immunotherapy of cancer 
using vaccination routes that generate Trm may be superior in generation of 
antitumor immunity (32, 33). In addition, reprogramming of infiltrating DCs in 
the tumor with curdlan induce a Trm phenotype in tumor-infiltrating T  cells 
that can reject tumors (34). The contribution of Trm to cancer immunity has 
been explored in several mouse cancer models. Using a mouse model of 
melanoma-associated vitiligo induced by depletion of regulatory T cells and 
surgical excision of a primary dermal B16 melanoma, functional melanoma 
antigen-specific Trm cells develop in the skin of mice with vitiligo and are cri-
tical for protection against melanoma rechallenge (10). Intranasal vaccination 
with a mucosal vector targeting DCs fused to an HSV-derived peptide leads 
to generation of Trm that are protective against an orthotopic head and neck 
TC1 tumor (11). Following skin scarification with rVACV-OVA, both circulating 
memory CD8+ T cells and Trm cells are sufficient to mediate immunity against 
B16-OVA melanoma (12). Surgical parabiosis of rVACV-OVA skin-scarified 
mice with naive mice leads to share circulating memory T cells while antigen-
specific Trm cells are restricted to the immunized parabiont. Challenge with 
melanoma of separate parabionts shows that circulating memory cells transfer 
antitumor immunity but this response is improved in the presence of Trm cells 
(12). In addition, Tcm cell infiltration in the tumor also induce the generation of 
cells with a Trm phenotype expressing PD-1, showing that anti-PD1 therapy 
can improve the effectiveness of Trm cells within the tumor (12). These results 
suggest that strategies aimed to enhance Trm generation or infiltration within 
tumors, in cooperation with circulating memory T cells, may result in improved 
cancer immunotherapy.
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generated by local tissue infection. In addition, Trm cells exhibit 
a unique transcriptional signature that comprises modulation 
of chemokine receptors like CXCR3 (4), upregulation of genes 
associated to tissue residency including Cdh1 (E-cadherin) (18), 
Itgae (CD103) (8, 19), and Itga1 (CD49a) (13, 20–22), and down-
regulation of genes related to tissue egress, such as Klf2, S1pr1 
(23), and Ccr7 (4, 24) among others. They also show augmented 
effector function compared with circulating memory cells, with 
elevated expression of Granzyme B and Tnf-a, and genes encod-
ing immunoregulatory molecules such as ICOS and CTLA-4, 
indicating tight modulation of the robust effector function of 
Trm cells (4, 24). Importantly, this transcription core is shared 
between human and mouse Trm cells (25–27).
Trm cells can be generated from KLRG1lo memory precur-
sors (4). These KLRG1lo memory precursors are either KLRG1− 
IL-7Rα+ memory precursor CD8+ effector T  cells or KLRG1+ 
effector cells that have lost KLRG1 expression (ExKLRG1) 
(35). These cells seed in non-lymphoid tissue where differential 
expression of transcription factors and tissue-derived signals 
instruct the tissue residency program of this T cell lineage. Trm 
formation requires partial downregulation of T-bet and com-
plete shutdown of eomesodermin (Eomes), being both events 
controlled by TGF-β derived from the tissue. Remaining T-bet 
is critical for IL-15R expression, which allows responsiveness 
to tissue-derived IL-15 necessary for their long-term survival 
(36). T-bet  along with IL-15 signaling are also critical for the 
expression of the transcription factor Hobit, that is essential for 
establishment of Trm cells in the tissue. Hobit cooperates with 
the transcription factor Blimp1 to control the transcriptional 
program of residency of Trm cells and concomitantly blocks the 
differentiation to alternative T  cell memory lineages (37) and 
regulates effector functions in quiescent human effector-type 
CD8+ T cells (38). In addition, the transcription factor Runx3 
is also a key regulator of Trm generation and modulates tissue 
residency (39).
Recent studies have revealed important contributors to Trm 
cell establishment and differentiation in the tissue (4–7, 23). 
However, less is known about the early priming signals in 
secondary lymphoid organs that precede entry into peripheral 
tissues (14). While both resident and circulating memory T cells 
have a common naive precursor (40), there are evidences sug-
gesting the existence of a committed Trm precursor. Modulation 
of T cell metabolic reprogramming affects Trm generation acting 
early after activation and determining T cell fate and function 
(41). Specifically, inhibition of mTOR by rapamycin during 
priming and expansion of CD8+ T  cells upon viral infection 
impairs the formation of Trm cells by blocking migration into 
the tissue, despite increasing the number of circulating memory 
T cells (41–43). This is consistent with data demonstrating that 
inhibition of mTOR induces Eomes and blocks persistent T-bet 
expression, favoring circulating memory T cell generation (44). 
These results suggest that differential modulation of mTOR-
dependent early signals received during T  cell activation can 
instruct circulating and memory compartments before tissue 
entry and differentiation. Moreover, cross-priming by type 1 
classical DCs (cDC1s) is required for optimal generation of Trm 
but not circulating memory cells, supporting the notion that 
priming signals can imprint acquisition of a committed Trm cell 
fate (14). However, Trm precursors are not only derived from 
naive T  cells, since antigen-experienced circulating memory 
T cells are also able to produce Trm cells after infection or in a 
tumor context (Box 1), highlighting the plasticity of the memory 
T  cell subsets, as explained below. We will thus discuss the 
genealogy of CD8+ Trm cell generation and the differential role 
of DCs during priming, differentiation, and reactivation of Trm 
cells, highlighting them as a strategy in vaccination and tumor 
immunotherapies.
GeNeRATiON OF MeMORY CD8+ T CeLL 
PReCURSORS
The traditional definition of memory T  cells is based on the 
survival time after infection, once antigen-specific T cell num-
bers stabilize, which normally occurs several weeks to months 
after priming. However, this survival-based definition does 
not take into account some key functional aspects of memory 
T cells that, on the other hand, define diverse memory subsets. 
These characteristics comprise the capacity of memory cells to 
develop rapid recall responses, the high proliferative capacity or 
stemness, and the homeostatic turnover. We could hypothesize 
that CD8+ T  cells do not acquire these memory-related func-
tional features until infection has been controlled, meaning that 
effector cytotoxic T lymphocytes only become Trm-committed 
cells once they have been established in their destination tissue. 
A B
B
FiGURe 1 | Possible models that explain the generation of a committed Trm precursor in secondary lymphoid organs. (A) One cell, one fate model. Distinct naive 
T cells will exhibit a different lineage decision determined by the quality (intensity of signal) of their TCR. (B) One cell, multiple fates model. B.1., Asymmetric cell 
division in T lymphocytes may determine fate diversification. B.2., Signal strength model. The strength of the signals 1, 2, and 3 determines the fate of the activated 
CD8+ T cells, with low strength signals generating central memory T (Tcm) precursors and high strength supporting the generation of terminal differentiated effectors. 
B.3., Decreasing potential model. This model proposes that a short duration of antigenic stimulation favors development of activated cells that will give rise to 
greater numbers of Tcm cells, while longer duration of stimulation promotes terminal effector cell differentiation and death.
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Alternatively, divergent differentiation fates of T  cell progeny 
could be specified when a naive T cell is activated during the acute 
phase of the immune response. Several evidences suggest that the 
fate of memory versus effector CD8+ T cells is determined early 
after priming or gradually during their development, meaning 
that memory cells are derived from early committed precursors 
(44–47). Notwithstanding, it is still not well understood whether 
this paradigm can be applied to Trm differentiation. The existence 
of an imprinted Trm precursor generated in secondary lymphoid 
organs is supported by the reconstitution of mature Trm cells 
upon KLRG1− adoptive transfer (4). In this study, CD8+ effector 
cells isolated from spleen of gBT-I.1 transgenic mice expressing 
a TCR specific for the MHC class I-restricted immunodominant 
peptide from HSV glycoprotein B (gB498-505) were sorted 
6 days after infection with HSV based on KLRG1 expression. The 
authors showed that, upon adoptive transfer, only the KLRG1− 
population generated matured CD103+ Trm cells in the skin 
of HSV-infected recipient mice. Moreover, Trm differentiation 
requires a distinct program that combines effector and memory 
cell transcriptional programs, sharing some features with early 
effector CD8+ T cells or Tem cells but also some of the Tcm cell 
properties (39, 48).
There are several models that explain generation of committed 
precursors for Tcm, Tem, and Trm cells (Figure 1). The “one cell, 
one fate” model (Figure 1A) proposes that distinct fates emerge 
from different naive T cells, with one single activated T cell giving 
rise to daughters of only one fate. In other words, this “one cell, 
one fate” model suggests that naive T cells are predetermined dur-
ing thymic development to give rise to effector or memory T cells. 
Therefore, we can speculate that specific TCR-bearing cells will 
give rise to circulating (Tcm or Tem) memory cells, while other 
CD8+ T clones expressing a different TCR will generate Trm 
cells. Nevertheless, Trm cell clones generated in the skin and Tcm 
cell clones in the draining lymph nodes (dLN) show a similar 
abundance of particular TCR clones tracked by CDR3 sequences, 
suggesting that a common naive T cell precursor is able to give 
rise to both Trm and Tcm cells after skin immunization (40). 
However, there may also be some pre-determination to become 
Trm or Tcm cells based on TCR-MHC interaction strength. For 
example, Trm cells in brain and kidney express TCRs with higher 
affinity to MHC-I tetramers (up to 20-fold) than their splenic 
memory T  cells counterparts, whereas effector cells express 
similar high-affinity TCRs in all organs (49). Conversely, low-
affinity T cells, with reduced T-bet expression during priming, 
preferentially differentiate into Tcm precursors (50). Similarly, 
different CD8 T cell clones have a distinct and fixed hierarchy 
in terms of effector function in response to the same Toxoplasma 
antigen measured as proliferation capacity, trafficking, T cell 
maintenance, and memory formation. Homing to the brain 
was directly related to TCR affinity. The highest affinity clone 
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persisted longer in the host during chronic infection as a resident 
memory population (CD103+) in the brain (51). These data 
suggest that the non-lymphoid microenvironment may facilitate 
the retention of T cells with high-affinity TCRs, particularly in 
persistent infections, which would facilitate detection of infected 
cells expressing low levels of antigen. We can thus conclude that 
although the “one cell, one fate” model does not always explain 
how a naive CD8+ T cell become a Trm or a circulating memory 
cell, the clonal TCR affinity may influence on this Trm cell fate 
or their persistence, depending on the nature of the infectious 
pathogen, or the infected target tissue where Trm cells establish.
Alternatively, it is possible that effector T cells and different 
memory T  cell subsets can derive from a single naive T  cell 
clone (Figure 1B). This “one cell, multiple fates” model, pro-
poses that the fate decision is taken during T cell priming or 
even in later stages during the T cell response. Several possible 
mechanisms may explain how different memory and effector 
subsets emerge from one single cell. During the immunologi-
cal synapse between the antigen-presenting cell and the T cell, 
asymmetric cell division (Figure  1B.1) allows the generation 
of two different daughter cells. Accordingly, the generation 
of effector and memory T cells from naive T cells in primary 
responses could depend on the asymmetric inheritance of 
intracellular fate determinants (52). However, the relevance 
of this asymmetric cell division in the generation of different 
memory precursors has not been determined yet.
In vivo cell tracking of individual OT-I cells demonstrated 
that, even for T cells with the same TCR, there are heterogene-
ous patterns of clonal expansion and differentiation. Therefore, 
the dynamics of the single-cell response are not uniform, as 
demonstrated by the differential participation of their progeny 
during primary versus recall infections. Therefore, individual 
naive T  lymphocytes contributed differentially to short- and 
long-term protection (53, 54). In addition, the progeny of naive 
clonal CD8+ T cells displayed unique profiles of differentiation 
based on extrinsic antiviral- or antibacterial-induced environ-
mental cues. A single naive CD8+ T cell exhibited distinct fates 
that were controlled by tissue-specific events (55, 56). Following 
oral infection with Listeria monocytogenes, an antigen-specific 
CD8 T cell population can be separated into cells with a memory 
precursor phenotype in the intestine, whereas in the spleen 
and lung, L. monocytogenes-specific CD8 T  cells maintained a 
prolonged short-lived effector phenotype. This intestinal CD127+ 
KLRG1− CD8 T cell population resembling memory precursor 
formed in response to TGF-β following oral L. monocytogenes 
infection. This subset rapidly upregulated CD103 needed for 
association to the epithelium and survived long-term, identifying 
mucosal Trm precursors (56). In either case, these observations 
exclude models in which each naïve T  cell exclusively yields 
progeny with the same distribution of either short- or long-term 
potential phenotype, arguing against asymmetric division as a 
singular driver of CD8+ T cell heterogeneity.
During priming, T  cells receive three key signals: antigen 
recognition (signal 1), co-stimulation (signal 2), and cytokines 
that modulate T cell differentiation (signal 3). According to the 
“Signal strength model” (Figure 1B.2), the strength of the three 
signals will determine the expansion amplitude and the fate of the 
primed T cell (57). Generation of short-lived or terminally dif-
ferentiated CD8+ T cells is favored by a strong pro-inflammatory 
signal (58), whereas precursors for Tcm cells are increased by 
the deficiency in type I interferon signaling (59), or deficiency in 
IFN-γ or IL-12 (60). Contrary to Tcm generation, inflammation 
drives Trm differentiation in several non-lymphoid tissues (9). 
Many tissue-specific cytokines including IL-15, TGF-β, IL-12, 
and type I IFN are produced upon infection and inflammation 
and regulate differentiation and persistence of Trm cells in non-
lymphoid tissues, with differential requirements that may be 
tissue specific (4, 61, 62).
The “decreasing potential model” (Figure  1B.3) states that 
the history and accumulative duration of signals that a CD8+ 
T cell has encountered during infection impacts on its differen-
tiation state. Repetitive antigen encounter and/or exposure to 
inflammatory cytokines, differentiates T cells toward terminal 
effector T  cells that retain their cytolytic capacity but lose 
features owned by Tcm cells, such as longevity, proliferative 
potential, and IL-7Rα expression. In this sense, and contrary to 
Tcm cells, local antigen presentation may favor the expansion of 
Trm cells in the skin (14, 63). The composition of the local Trm 
cell pool is shaped by antigen-dependent competition between 
CD8+ T cells of different specificities in the infected tissue (64). 
Therefore, Trm cells development seems to be favored by antigen 
encounter and/or specific inflammatory signals in the tissue that 
favor, or are even needed for their retention (4, 9, 65). Regardless 
of the apparently contradictory different mechanisms proposed 
by these models, they are not necessarily mutually exclusive 
and multiple models may simultaneously contribute to in vivo 
induction of memory T cells.
PLASTiCiTY AMONG DiFFeReNT T CeLL 
SUBSeTS
Independently of the existence or not of a committed Trm pre-
cursor, it is well documented that naive (CD8+CD44−CD62L+) 
T  cells differentiate into Trm cells in multiple scenarios: skin 
infection with VACV (3), or HSV (66), intranasal infection with 
influenza (67) or in non-infectious disorders, such as chemical 
hapten inflammation (40). In several cases, optimal generation 
of committed Trm precursors requires further antigen presenta-
tion in the inflamed tissue (Figure 2A). However, Trm differen-
tiation and maintenance is dependent on tissue-specific signals 
that may be antigen independent. Inflammation drives Trm 
differentiation in many non-lymphoid tissues (9) (Figure 2B). 
Many tissue-specific cytokines including IL-15, TGF-β, IL-12, 
and type I IFN are produced upon infection and inflammation 
and regulate differentiation and persistence of Trm cells in 
non-lymphoid tissue, with differential requirements that may be 
tissue specific (4, 61, 62). Effector CD8+ T cells can also differ-
entiate into nasal Trm cells independently of local antigen (68) 
(Figure 2C). However, it is difficult to know if the conversion of 
effector T cells into Trm occurs in all effector cells infiltrating 
the tissues, or whether there are specific features in the effector 
T cells that commit them to Trm differentiation under the right 
tissue environment, as we have discussed in the former section.
FiGURe 2 | Genealogy of Trm. (A) During primary infection, immunization, or other insults, naive T lymphocytes differentiate into precursors of circulating  
memory cells, effectors, and putative precursors of Trm (pre-Trm) cells that can differentiate into Trm cells in the skin, in response to viruses (VACV/HSV) or  
tumors. (B,C) Inflammation in the intestine (B) or in the upper respiratory tract (C) is able to promote Trm generation. (D) In the female reproductive tract, 
proliferating pre-existing Trm cells contribute substantially to the boosted secondary Trm population and can exit non-lymphoid tissues to convert into new  
Trm cells in lymphoid tissues. (e) Under steady-state conditions, circulating memory T cells can differentiate into Trm cells in the lung of mice previously  
infected with influenza A virus. (F) Circulating memory [effector memory T (Tem) or central memory T (Tcm)] cells can differentiate into Trm cells in the skin  
upon secondary challenge with viruses or tumors.
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In steady state or upon challenge, Trm cells may also be 
generated from antigen-experienced cells: Tcm, Tem, and Trm 
cells themselves (self-maintenance) (65, 69–71). Local antigen 
reactivation of pre-existing Trm in the female reproductive tract 
(70) or the skin (69) results in their arrest and in situ division 
(Figure 2D). These proliferating Trm also exhibit some plasticity 
and can exit non-lymphoid tissues to convert into new Trm in 
the draining lymphoid tissue (71, 72) (Figure  2D). Although 
local mucosal recall response is dominated by proliferating pre-
existing Trm that contribute most substantially to the boosted 
secondary Trm population, Trm reactivation also induces the 
antigen-independent recruitment of Tcm that differentiate 
into Trm in  situ (69, 70). Maintenance of a Trm pool in the 
lung by conversion of incoming circulating memory CD8+ 
T cells is critical for protection after influenza A virus infection 
(73). Lung Trm cells are replenished mainly from circulating 
CD8+CD69−CD103− Tem rather than Tcm cells, even in the 
absence of persisting antigen (Figure  2E). However, this lung 
Trm pool declines with time as circulating memory CD8+ T cells 
lose migratory capacity to the lung, together with an enrichment 
of Tcm versus Tem among circulating population of memory 
cells, thus reducing the efficiency of conversion to Trm cells. 
These findings support a model where gradual loss of protection 
to influenza is linked to a decline of Trm cells in the lungs caused 
by apoptosis and decreased input from the circulating memory 
CD8+ T cell population (73).
A B
C
FiGURe 3 | Differential role of antigen-presenting cells in priming, expansion/differentiation, and reactivation of tissue-resident memory T cells. (A) In mice, optimal 
generation of Trm in response to VACV or Flu requires CD8+ T cells cross-priming by DNGR-1+ dendritic cells (cDC1, CD8α+, and CD103+), while circulating memory 
T cells could be primed by both CD11bhi (cDC2) or cDC1. Naive T cells cross-primed by cDC1 receive CD24 co-stimulation, IL-15 and IL-12 specifically produced 
by this dendritic cell (DC) subset, contributing to the generation of committed Trm precursors. (B) Monocytes (Ly6C+) and monocyte-derived DC (Mo-DCs) 
contribute to expansion of Trm in response to HSV or Yersinia by secretion of inflammatory cytokines, and also modulate the generation/differentiation of specific 
Trm subpopulations (CXCR3hiCX3CR1lo; CD69+CD103−). In addition, reactivation of Trm cells in response to HSV-2, requires MHC-I expression in CD301b+ DC.  
(C) Notably, human CD1c+, but not CD141+, induce CD103 expression on CD8+ T cells and their accumulation in the lung, in a process dependent on TGF-β1.
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Transfer of CD8+CD44+CD62L+ Tcm cells specific for 
ovalbumin (OT-I) followed by epicutaneous VACV-OVA infec-
tion also induced Trm cells in the skin (12) (Figure 2F). The 
efficiency of Trm generation is, however, not equal depending 
on the different T cell source. For example, although both Tcm 
and naive T cells induce Trm cells that persist at least 2 months 
after infection, Tcm cells are less efficient at producing Trm 
cells (12). Most Trm cells generated from adoptively transferred 
Tcm cells showed hallmark CD69 expression, with half of them 
co-expressing CD103. Trm cells derived from adoptively trans-
ferred Tcm cells were unable to migrate via blood or lymph (12), 
supporting that they are bona fide Trm cells without recirculat-
ing capacity (74). Plasticity of transferred Tcm to become Trm 
cells does not only occur upon infection but also in the context 
of tumor challenge. Mice transferred with OVA-specific Tcm 
cells and challenged with intradermal inoculation of B16-OVA 
melanoma developed cells with a Trm cell phenotype (CD69+ 
CD103+) within the tumor mass. Furthermore, when mice 
transferred with Tcm cells were challenged with MC38-OVA 
colon adenocarcinoma, CD69+CD103+ OVA-specific CD8+ 
T  cells were found in the skin proximal to rejected MC38-
OVA tumors 45 days after inoculation (Box 1) (12). However, 
whether the conversion of Tcm into Trm occurs directly or is 
mediated by Tcm conversion into effector or Tem needs to be 
further studied.
DCs DRive Trm CeLL PRiMiNG AND 
ReACTivATiON
While most of the studies in Trm generation and development 
have focused on differentiation and maintenance dependent on 
specific tissue-derived signals, priming of committed precursors 
in the secondary lymphoid organs has been less explored. The 
analysis of mice deficient in DNGR-1 or Batf3 (75, 76) has shown 
the relevance of cDC1 in priming of CD8+ T cell memory subsets. 
High expression of DNGR-1 is restricted to the cDC1 subset, 
where DNGR-1 plays an essential role in cross-presentation to 
VACV antigens (77, 78). In addition, the cDC1 subset depends 
on the Batf3 transcription factor for their development and/or 
function (76, 79). Deficient cross-presentation by cDC1 results 
in a threefold reduction in the numbers of Trm cells in a model 
of skin VACV infection, while circulating memory CD8+ T cells 
are not affected (14) (Figure 3A). The cDC1 subset provides the 
antigen for priming by cross-presentation in this context of infec-
tion, but also provide specific signals 2 (CD24) and 3 (IL-12 and 
7
Enamorado et al. Priming and Differentiation of Trm
Frontiers in Immunology | www.frontiersin.org July 2018 | Volume 9 | Article 1751
IL-15) (47, 80–83). These specific priming signals from cDC1s 
are also essential for optimal priming of Trm precursors (14), 
suggesting that priming by cDC1s is key for optimal Trm cell 
priming in this context of VACV infection, and cross-priming is 
the operational manner in which the antigen is presented in this 
setting. The key role of cDC1 for priming of Trm cells could be 
extended to additional infection models: for example, targeting 
malaria antigen to DNGR-1-expressing cDC1s in the presence of 
adjuvant generates Trm cells in the liver upon trapping primed 
T  cells with a recombinant adeno-associated virus that targets 
hepatocytes to express the same malaria antigen (84).
Following viral infection, cross-priming transiently induces 
T-bet and its target CXCR3 in CD8+ T lymphocytes in the dLN, 
correlating with the generation of Trm precursors (14). T-bet 
induction at priming may contribute to longer retention in the LN 
of T cells that eventually egress to the tissue with low expression of 
T-bet and KLRG1. Consistent with the notion that high expression 
of T-bet inhibits Trm differentiation in the skin (36, 85), cross-
priming ultimately favors T cells with delayed egress and lower 
expression of T-bet and KLRG1 in the skin (14). In addition, cross-
priming transiently phosphorylates Foxo1 in CD8+ T cells (14), 
resulting in its degradation that favors retention of CD8+ T cells in 
the LN. However, cross-priming deficiency does not affect expres-
sion of the transcription factor Eomes, involved in Tcm generation 
(44, 58). Thus, this early transcriptional regulation by cross-priming 
does not affect effector or circulating memory CD8+ T cell deve-
lopment, IFN-γ production, or viral clearance mediated by CD8+ 
T cells. However, the analysis of CD103+ Trm cell differentiation 
in the skin revealed that formation of CD103+CD8+ T cells was 
slower between 7 and 14 days in the absence of cross-priming, 
suggesting a lower number of Trm cell precursors seeding the 
skin. Impaired Trm but not Tcm cell generation in vaccinated 
DNGR-1-deficient mice results in defective viral clearance (14).
Cross-priming through cDC1 also results in more prolonged 
downregulation of KLF2 and S1P (14). Downregulation of the 
KLF2-dependent S1P receptor leads to retention during prim-
ing (86). Weak priming in the absence of cross-presentation by 
cDC1s leads to early upregulation of KLF2 and S1P, leading to 
early egress of KLRG1+ cells that are not Trm precursors (4, 14) 
and migrate to the skin to generate terminal effector CD8+ T cells 
(58, 87). Once in the skin, inflammatory signals downregulate 
again KLF2 and S1P contributing to retention (23). Consistently, 
the inhibition of T cell egress with FTY720 treatment increases 
generation of both circulating memory and Trm cells in WT 
mice, partially rescuing the defect in Trm cell generation in mice 
deficient in cross-priming by cDC1s (14). These data highlight 
that retention of CD8+ T cells during priming in the LN favors 
Trm cell generation. However, it is not sufficient to compensate 
the specific signals provided by Batf3-dependent DNGR-1+ DCs. 
In vitro co-culture of CD8+ T cell with different DC subsets shows 
that CD103+ and CD8α+ DC (cDC1s) but not CD11bhi CD8α− 
(cDC2s) induce generation of Trm cells, in a DNGR-1-dependent 
fashion. The blockade of specific priming signals provided by 
cDC1s such as CD24, IL-12, and IL-15 reduces T-bet induction 
and generation of Trm precursors; however, cDC1 priming 
blockade does not affect the generation of circulating memory 
T cells (14).
It is debated to which extent antigen presentation (signal 1), 
co-stimulation (signal 2), or cytokines (signal 3) derived from 
different DC subsets are required for differentiation and for 
reactivation upon rechallenge. The requirement of antigen for 
Trm cell differentiation in tissues has been described (3, 14, 
66, 67). Antigen recognition within the tissue drives expres-
sion of CD103 by brain Trm cells (8). The restimulation of 
Trm cells and induction of IFN-γ is dependent on MHC-I 
expression on CD301b+ DC (Figure 3B), while inflammatory 
cytokines alone are likely not sufficient by themselves for full 
activation of Trm cells responding to genital HSV-2 infection 
(88). However, antigen presentation is dispensable for Trm 
generation in other systems (4, 9, 89), supporting the notion 
that the particular pathogen or inflammatory insult triggers 
a distinct response that determines the requirements for Trm 
differentiation (40). Inflammatory signals derived from myeloid 
cells can also impact in the Trm cell phenotype (Figure  3B). 
Recruitment of monocyte-derived DCs in the LNs is required 
for the activation of HSV-specific CD8+ Trm cells (66). Ly6C+ 
inflammatory monocytes contribute to the persistence, but not 
generation, of lung memory CD8+ Trm cells, affecting selectively 
to a CXCR3hiCX3CR1lo subset upon VACV intranasal challenge 
(90). Moreover, IFN-β and IL-12 derived from monocyte-
derived intestinal macrophages during Yersinia infection, favors 
the differentiation of CD69+CD103− Trm cells (Figure 3B) (62).
While cDC1s are essential for optimal priming, they are 
dispensable for differentiation in the skin, which also requires 
antigen presentation in the VACV infection model (14). Thus, 
different DC subsets may work cooperatively in the LN prim-
ing of Trm precursors and differentiation in the skin in an 
antigen-cognate fashion. However, the requirement of antigen 
presentation by different DC subsets may be model dependent. 
XCR1+ cDC1 seem to be necessary to promote recall of circu-
lating memory CD8+ T  cells upon secondary infections with 
pathogens such as L. monocytogenes or certain viruses (91), or in 
response to tumors (12). But this particular DC subset does not 
seem to play a role in the maintenance of Trm cells upon viral 
infection (14). In a mouse model of HSV-2 intravaginal infec-
tion, depletion of CD301b+ cDC2 results in significantly worse 
clinical symptoms, higher weight loss, and mortality after viral 
rechallenge (88). However, CD301b+ cDC2 depletion does not 
affect circulating memory, while stimulates the differentiation 
and antiviral function of vaginal CD8+ Trm cells (Figure  3B). 
Accordingly, CD301b+ cDC2 depletion has minimal impact on 
disease severity and weight loss when protection is exclusively 
dependent on circulating memory CD8+ T cells (88).
In comparison to murine DCs, less is known about the func-
tion of human DCs in tissues. By using lung tissues from humans 
and humanized mice, it has been found that both lung DC sub-
sets (CD1c+ and CD141+) acquire antigens from live-attenuated 
influenza virus in  vivo and expanded specific cytotoxic CD8+ 
T  cells in  vitro (Figure  3C). However, lung tissue-resident 
CD1c+ DC but not CD141+ DC induce CD103 expression on 
CD8+ T cells and promoted CD8+ T cell accumulation in lung. 
Induction of CD103 expression mediated by CD1c+ DCs was 
dependent on TGF-β1. Thus, CD1c+ and CD141+ DCs generate 
CD8+ T cells with different properties (92). The results discussed 
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above are consistent with the notion of division of tasks among 
DC subsets during the priming and differentiation of Trm 
cells, although the particular role of a DC subset or even the 
dependence on antigen presentation or priming by DC-derived 
cytokines may depend on the particular settings in which Trm 
cells are generated.
CONCLUDiNG ReMARKS
Following immunization, DCs in the secondary lymphoid organs 
prime CD8+ T  cells for generation of effector and memory 
responses, but there are different flavors of memory T cells 
and the specific requirements for priming, differentiation, and 
reactivation of each subset are different. Tissue-resident memory 
CD8+ T (Trm) cells represent the newest layer of complexity in 
memory subsets. By virtue of their location, they act as sensor 
and effector cells, triggering both innate and adaptive responses, 
therefore providing a superior immunity against reinfection in 
the tissue (3, 4, 93).
Current evidences support the idea that Tcm, Tem, and 
Trm cells are generated from common precursors that are 
committed upon differential priming in secondary lymphoid 
organs (14, 40). Asymmetric inheritance of intracellular fate 
determinants could explain generation of effector and memory 
T cells from clonal naive T cells (52). TCR affinity and duration 
of signals during priming can also determine the T  cell fate, 
with Trm cells linked to high-affinity TCR and Tcm cells to low 
affinity (49, 94).
Naive T cells differentiate into Trm in many scenarios: infec tious 
and even non-infectious, such as chemical hapten inflammation 
(3, 12, 40, 66, 67). However, independently of the generation of 
Trm cells from naive cells primed in the LN, there is some degree 
of plasticity among T  cell subsets. Trm cells can be generated 
from antigen-experienced cells such as effector CD8+ T  cells, 
Tcm, Tem, or even Trm cells (self-maintenance). Several factors 
may condition the relative efficiency of Trm generation from 
difference sources, including the type of challenge (infection, 
inflammation), the presence of specific antigen driving reactiva-
tion and tissue-specific signals that can promote Trm generation 
in an antigen-independent fashion (12, 70, 71, 73).
Different subsets of DCs may affect differentially the priming 
of Trm precursors. cDC1s drive priming of Trm precursors in 
the LN, but not Trm tissue differentiation, in a VACV skin infec-
tion model, and targeting malaria antigen to cDC1s generates 
antigen-specific Trm in the liver, requiring both models antigen 
presence in the target tissue (14, 84). Antigen presentation and 
inflammatory cytokines produced by other myeloid cell subsets 
contribute to Trm differentiation (62, 88, 90, 92), suggesting a 
division of tasks among DC subsets in the priming and differen-
tiation of memory T cell subsets that can be model dependent. 
Further dissection of how DC prime and generate different 
memory T cell subsets, what are the requirements for differentia-
tion and effector function of each subset, and how these memory 
T cell subsets act in concert to induce optimal immunity will be 
important to improve current immunotherapy strategies against 
pathogens or cancer.
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